A recent article published by Kontan discusses bilateral cooperation between Indonesia and the United Arab Emirates related to the pharmaceutical and medical device industries.
According to the reporting, Indonesian Minister of Health, Budi Gunadi Sadikin, met with Deputy Assistant Secretary of Public Health Policy and Licensing, Ministry of Health and Prevention of the United Arab Emirates (UAE) Amin Al Ameeri at the Business Forum on the visit of MOHAP EUA and announced that Indonesia “will start the collaboration of the pharmaceutical and medical device industry with the UAE.”
Sadikin said that one of the main focuses of the cooperation between the two countries is to build more research and distributed production capacity on vaccines, therapies, and diagnostics (VTD), which will provide greater equity and access for each country when the next pandemic hits.
This is because entering the third year of the pandemic, the world is still facing COVID-19 and the threat of its new variant. For this reason, access to VTDs and improvement of the health care system are vital components that need to be strengthened to anticipate the surge in COVID-19 cases and end the acute phase of the pandemic.
With Indonesia’s position as a home for more than 5-vaccine manufacturers, 220-pharmaceutical manufacturers, and more than 650-medical device manufacturers, most of which have been recognized in global standards, with experience in exporting products to all over the world, the Minister of Health is optimistic that Indonesia has enormous potential to help meet the global supply of pharmaceuticals and medical devices.
This collaboration is expected to be a way for strengthening a resilient global health architecture against the threat of health disasters in the future.
“We believe bilateral partnerships are one way to achieve better health care, a more resilient health system, and contribute to global efforts in dealing with pandemics in the future,” said Sadikin, who expressed his hope that this collaboration will be a great opportunity and a good start in the framework of strengthening the global health architecture which was under pressure due to the COVID-19 pandemic. He hoped that the cooperation in the health sector between the two countries could continue to be improved.